• CDC News
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Weight Management
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Kidney Disease
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

ESMO: Radiation Plus Hormone Therapy Is Prostate Cancer Plus

Article

ISTANBUL, Turkey -- Progression-free survival is prolonged by 10% in men with locally advanced prostate cancer who receive both radiation and hormone therapy, according to a large meta-analysis.

ISTANBUL, Turkey, Oct. 6 -- Progression-free survival is prolonged by 10% in men with locally-advanced prostate cancer who receive both radiation and hormone therapy, Italian researchers reported here.

In a meta-analysis of 4,373 patients who had participated in seven randomized controlled phase III trials, there was a relative risk of relapse of 0.74 (95% confidence interval, 0.70, 0.78, P

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2025 MJH Life Sciences

All rights reserved.